NHS Scotland to provide £100,000-per-year cystic fibrosis drug

12:11 EDT 13 Sep 2019 | The Pharmaceutical Journal

A five-year deal to supply NHS Scotland with cystic fibrosis drugs Orkambi and Symkevi has been secured after discussions between the manufacturer, Vertex Pharmaceuticals, and the Scottish government.

Original Article: NHS Scotland to provide £100,000-per-year cystic fibrosis drug


More From BioPortfolio on "NHS Scotland to provide £100,000-per-year cystic fibrosis drug"

Quick Search

Relevant Topics

Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...